Supplier | Sun Pharmaceutical Industries, Inc. |
---|---|
Availability Status | ASHP Shortage + QS Availability Issues (2024-07-22) |
Status Description |
QuicksortRx has identified an availability disruption across multiple channels, and ASHP has published an active drug shortage for this product. See their website for more information. |
Quicksort Status | Availability Issues Detected (2024-07-22) |
ASHP Status | ASHP Shortage Declared (2023-11-22) |
QUMI Product Code | eceh351 (QuicksortRx Universal Medication Identifier) |
NDC | Package Count | Supplier | Description | Status | Updated |
---|---|---|---|---|---|
90 | Mylan Pharmaceuticals Inc. | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | SpecGx LLC | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Lannett Company, Inc. | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Rhodes Pharmaceuticals | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Solco Healthcare US,LLC | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Ascent Pharmaceuticals, Inc. | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Alvogen Inc. | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Takeda Pharmaceuticals America, Inc. | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected | ||
100 | Apotex Corp. | Lisdexamfetamine dimesylate 10 mg Oral Capsule [Vyvanse] | No Availability Issues Detected |
Previous Status | Status Start Date | Status End Date |
---|---|---|
ASHP Shortage + QS Availability Issues | 2024-07-22 | Current |
No Availability Issues Detected | 2024-07-22 |
RXCUI: | 1593856 |
---|---|
Dosage Form: | Oral Capsule |
Dosage Route: | ORAL |
Strength: | 10 |
Measure: | mg |
ANDA: | ANDA214484 |
Generic Description: | LISDEXAMFETAMINE DIMESYLATE |
DEA: | 2 |